Doseloop Beta

Zaleplon

medication Under review

A nonbenzodiazepine sedative-hypnotic medication used for the short-term treatment of insomnia.

Research summary

AI-Generated Content: This summary was created by AI and may contain errors. Always verify with peer-reviewed sources.

Scientific evidence from clinical studies in healthy volunteers shows zaleplon effectively reduces sleep latency and supports sleep onset without persistent impairment in cognitive, memory, or psychomotor performance beyond a few hours. Research consensus highlights its favorable profile for middle-of-the-night dosing due to rapid clearance, with no significant next-day sedation observed in controlled settings. However, evidence is limited to short-term use, and long-term effects in healthy populations remain underexplored.

Reported Benefits

Reported Side Effects

Research (2 studies)

RCT

Clinical evaluation of zaleplon in the treatment of insomnia

PMC (Therapeutics and Clinical Risk Management) • 2013 • n=16

Not specified in excerpt

RCT

Zaleplon, A Novel Nonbenzodiazepine Hypnotic, Effectively Treats Insomnia in Elderly Patients Without Causing Rebound Effects.

PMC (Journal of Clinical Psychiatry) • 2000 • n=5

Not specified in excerpt

Community updates

No updates yet for this supplement.

Be the first to share your experience!

At a glance

Users tracking 0
Linked studies 2
Researched benefits 1
Side effects noted 3